Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.91 USD | -2.94% | -9.39% | +6.75% |
Business Summary
Number of employees: 8
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Proprietary Medicinal Products
100.0
%
| 0 | nan % | 6 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | nan % | 6 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Howard Berman
CEO | Chief Executive Officer | 50 | 01/20/01 |
Fred Grossman
PSD | President | 62 | 17/23/17 |
David Snyder
DFI | Director of Finance/CFO | 63 | 30/22/30 |
Michelle Frazier
LAW | General Counsel | - | 14/23/14 |
Arun Swaminathan
PRN | Corporate Officer/Principal | - | 27/23/27 |
John M. Centanni
LAW | General Counsel | - | 01/22/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Wilbur Ross
BRD | Director/Board Member | 85 | 19/12 |
Dov Goldstein
BRD | Director/Board Member | 56 | 14/21/14 |
Hideki Garren
BRD | Director/Board Member | 60 | 01/21/01 |
Dieter Weinand
BRD | Director/Board Member | 63 | 18/23/18 |
Director/Board Member | 65 | 25/21/25 | |
Ann Lee
BRD | Director/Board Member | 62 | 01/21/01 |
Howard Berman
CEO | Chief Executive Officer | 50 | 01/20/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 14,618,172 | 12,966,956 ( 88.70 %) | 0 | 88.70 % |
Company contact information
Coya Therapeutics, Inc.
5850 San Felipe Street Suite 500
77057, Houston
+
http://www.coyatherapeutics.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.75% | 124M | |
+67.53% | 62.86B | |
-0.77% | 41.38B | |
+45.66% | 40.38B | |
-10.72% | 27.64B | |
+13.30% | 26.46B | |
-22.79% | 18.9B | |
+4.70% | 12.67B | |
+24.10% | 12.27B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- COYA Stock
- Company Coya Therapeutics, Inc.